POSOCCO, BIANCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.226
AS - Asia 2.002
EU - Europa 761
SA - Sud America 297
AF - Africa 273
Continente sconosciuto - Info sul continente non disponibili 42
OC - Oceania 21
Totale 5.622
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.039
SG - Singapore 603
VN - Vietnam 469
CN - Cina 322
BR - Brasile 195
IT - Italia 156
HK - Hong Kong 146
BD - Bangladesh 120
DE - Germania 104
FI - Finlandia 77
FR - Francia 53
IN - India 46
CA - Canada 44
PL - Polonia 39
GB - Regno Unito 36
RU - Federazione Russa 36
TR - Turchia 27
NL - Olanda 24
AR - Argentina 23
PK - Pakistan 22
ZA - Sudafrica 22
MX - Messico 19
UA - Ucraina 19
EC - Ecuador 18
SA - Arabia Saudita 18
AT - Austria 17
JP - Giappone 17
IQ - Iraq 16
KR - Corea 16
ID - Indonesia 15
PY - Paraguay 15
SE - Svezia 15
CO - Colombia 14
GE - Georgia 13
MA - Marocco 13
DK - Danimarca 12
HN - Honduras 12
BJ - Benin 11
CL - Cile 11
EG - Egitto 11
GT - Guatemala 11
NI - Nicaragua 11
BB - Barbados 10
HR - Croazia 10
KG - Kirghizistan 10
RO - Romania 10
AL - Albania 9
AO - Angola 9
IE - Irlanda 9
JO - Giordania 9
LV - Lettonia 9
ML - Mali 9
SN - Senegal 9
TH - Thailandia 9
YT - Mayotte 9
AD - Andorra 8
BA - Bosnia-Erzegovina 8
CR - Costa Rica 8
CV - Capo Verde 8
ES - Italia 8
GN - Guinea 8
LA - Repubblica Popolare Democratica del Laos 8
MG - Madagascar 8
MY - Malesia 8
NP - Nepal 8
PH - Filippine 8
PT - Portogallo 8
RE - Reunion 8
BF - Burkina Faso 7
BY - Bielorussia 7
CG - Congo 7
CI - Costa d'Avorio 7
CW - ???statistics.table.value.countryCode.CW??? 7
DO - Repubblica Dominicana 7
DZ - Algeria 7
GM - Gambi 7
IL - Israele 7
LU - Lussemburgo 7
MD - Moldavia 7
PS - Palestinian Territory 7
TT - Trinidad e Tobago 7
UZ - Uzbekistan 7
AZ - Azerbaigian 6
BZ - Belize 6
CZ - Repubblica Ceca 6
ET - Etiopia 6
GP - Guadalupe 6
GR - Grecia 6
IR - Iran 6
JM - Giamaica 6
KE - Kenya 6
LT - Lituania 6
LY - Libia 6
MK - Macedonia 6
MN - Mongolia 6
MR - Mauritania 6
NA - Namibia 6
NZ - Nuova Zelanda 6
PA - Panama 6
PE - Perù 6
Totale 5.338
Salva come PNG Salva come JPEG
Città #
Ashburn 426
Singapore 409
San Jose 333
Ho Chi Minh City 154
Hanoi 137
Hong Kong 134
Fairfield 104
Santa Clara 89
Chandler 85
Beijing 84
Munich 68
New York 48
Houston 47
Los Angeles 43
Cambridge 41
Seattle 41
Ann Arbor 40
Helsinki 38
Boardman 35
Woodbridge 34
Buffalo 33
Bytom 29
Wilmington 28
Lauterbourg 27
Da Nang 22
São Paulo 22
Chicago 21
Turku 21
Dallas 20
Milan 20
San Diego 19
Princeton 16
Guangzhou 15
Medford 14
Montreal 14
London 13
Orem 13
Rome 13
Haiphong 12
Hefei 12
Tokyo 12
Toronto 12
Cotonou 11
Council Bluffs 11
Johannesburg 11
Managua 11
Bridgetown 10
Chennai 10
Vienna 10
Bishkek 9
Bến Tre 9
Falkenstein 9
Jeddah 9
Lahore 9
Naples 9
Amman 8
Andorra la Vella 8
Biên Hòa 8
Brooklyn 8
Cairo 8
Conakry 8
Dakar 8
Guayaquil 8
Hải Dương 8
Kyiv 8
Riga 8
Rio de Janeiro 8
San Francisco 8
Trieste 8
Amsterdam 7
Ankara 7
Baghdad 7
Des Moines 7
Luanda 7
Minsk 7
Praia 7
Salt Lake City 7
Tirana 7
Abidjan 6
Baku 6
Bamako 6
Brazzaville 6
Copenhagen 6
Frankfurt am Main 6
Guatemala City 6
Jacksonville 6
Kampala 6
Kigali 6
Lappeenranta 6
Luxembourg 6
Nairobi 6
Nha Trang 6
Ninh Bình 6
Nouakchott 6
Panama City 6
San José 6
Thái Bình 6
Ulan Bator 6
Vientiane 6
Auckland 5
Totale 3.232
Salva come PNG Salva come JPEG
Nome #
Field-assisted paper spray mass spectrometry for therapeutic drug monitoring: 1. the case of imatinib in plasma 248
Cross-validation of a mass spectrometric-based method for the therapeutic drug monitoring of irinotecan: implementation of matrix-assisted laser desorption/ionization mass spectrometry in pharmacokinetic measurements 230
A new high-performance liquid chromatography–tandem mass spectrometry method for the determination of sunitinib and N-desethyl sunitinib in human plasma: Light-induced isomerism overtaking towards therapeutic drug monitoring in clinical routine 230
A new dried blood spot LC-MS/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer 222
NPQ activation reduces chlorophyll triplet state formation in the moss Physcomitrella patens 219
Exploring pharmacokinetic variability of palbociclib in HR+/HER2- metastatic breast cancer: a focus on age, renal function, and drug-gene interactions 212
Impact of ABCG2 and ABCB1 Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis 206
Light driven water oxidation by a single site cobalt salophen catalyst 204
The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failure 202
A LC–MS/MS method for therapeutic drug monitoring of sorafenib, regorafenib and their active metabolites in patients with hepatocellular carcinoma 197
Analytical aspects of sunitinib and its geometric isomerism towards therapeutic drug monitoring in clinical routine 194
Simultaneous quantification of palbociclib, ribociclib and letrozole in human plasma by a new LC-MS/MS method for clinical application 191
Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancer 187
Development and validation of LC-MS/MS method for imatinib and norimatinib monitoring by finger-prick DBS in gastrointestinal stromal tumor patients 184
An SPR investigation into the therapeutic drug monitoring of the anticancer drug imatinib with selective aptamers operating in human plasma 184
Therapeutic Monitoring of Palbociclib, Ribociclib, Abemaciclib, M2, M20, and Letrozole in Human Plasma: A Novel LC-MS/MS Method 178
Field-assisted paper spray mass spectrometry for the quantitative evaluation of imatinib levels in plasma 177
Dried Blood Spot Technique Applied in Therapeutic Drug Monitoring of Anticancer Drugs: a Review on Conversion Methods to Correlate Plasma and Dried Blood Spot Concentrations 175
An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast Cancer 172
Bioanalytical Methods for Poly(ADP-Ribose) Polymerase Inhibitor Quantification: A Review for Therapeutic Drug Monitoring 168
Clinical impact of body mass index on palbociclib treatment outcomes and effect on exposure 165
A rapid, simple and sensitive LC-MS/MS method for lenvatinib quantification in human plasma for therapeutic drug monitoring 163
LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring 162
A new LC-MS/MS method for the simultaneous quantification of abemaciclib, its main active metabolites M2 and M20, and letrozole for therapeutic drug monitoring 161
Quantification of Letrozole, Palbociclib, Ribociclib, Abemaciclib, and Metabolites in Volumetric Dried Blood Spots: Development and Validation of an LC-MS/MS Method for Therapeutic Drug Monitoring 158
Increased plasma imatinib exposure and toxicity in chronically treated GIST patients with SARS-CoV-2 infection: a case series 157
Mass spectrometry in the pharmacokinetic studies of anticancer natural products 154
Therapeutic drug monitoring of palbociclib, ribociclib and letrozole in women with breast cancer by LC-MS 154
The development of a matrix-assisted laser desorption/ionization (MALDI)-based analytical method for determination of irinotecan levels in human plasma: Preliminary results 141
A fast and validated LC-MS/MS method to quantify lenvatinib in dried blood spot 135
Matrix-assisted laser desorption/ionization, nanostructure-assisted laser desorption/ionization and carbon nanohorns in the detection of antineoplastic drugs. 1. The cases of irinotecan, sunitinib and 6-alpha-hydroxy paclitaxel 92
Totale 5.622
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.322
article - articoli 16.322
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.644
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022184 8 20 13 11 4 28 10 16 9 14 15 36
2022/2023185 25 22 3 26 32 17 0 9 28 4 13 6
2023/2024122 6 16 6 11 9 27 11 6 10 3 11 6
2024/2025905 1 79 40 36 77 52 30 83 44 44 146 273
2025/20263.755 216 218 461 457 379 150 639 313 377 207 216 122
2026/2027129 129 0 0 0 0 0 0 0 0 0 0 0
Totale 5.622